Your browser doesn't support javascript.
loading
Caloric restriction leading to attenuation of experimental Alzheimer's disease results from alterations in gut microbiome.
Chen, Junyu; Zou, Cong; Guan, Hongbing; Zhou, Xiaoming; Hou, Le; Cui, Yayong; Xu, Junhua; Luan, Ping; Zheng, Dong.
Afiliação
  • Chen J; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zou C; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Guan H; Guangdong Yunzhao Medical Technology Co., Ltd., Guangzhou, China.
  • Zhou X; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Hou L; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Cui Y; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Xu J; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
  • Luan P; School of Basic Medical Sciences, Shenzhen University, Shenzhen, China.
  • Zheng D; Department of Neurology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China.
CNS Neurosci Ther ; 30(7): e14823, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38992870
ABSTRACT

BACKGROUND:

Caloric restriction (CR) might be effective for alleviating/preventing Alzheimer's disease (AD), but the biological mechanisms remain unclear. In the current study, we explored whether CR caused an alteration of gut microbiome and resulted in the attenuation of cognitive impairment of AD animal model.

METHODS:

Thirty-week-old male APP/PS1 transgenic mice were used as AD models (AD mouse). CR was achieved by 30% reduction of daily free feeding (ad libitum, AL) amount. The mice were fed with CR protocol or AL protocol for six consecutive weeks.

RESULTS:

We found that with CR treatment, AD mice showed improved ability of learning and spatial memory, and lower levels of Aß40, Aß42, IL-1ß, TNF-α, and ROS in the brain. By sequencing 16S rDNA, we found that CR treatment resulted in significant diversity in composition and abundance of gut flora. At the phylum level, Deferribacteres (0.04%), Patescibacteria (0.14%), Tenericutes (0.03%), and Verrucomicrobia (0.5%) were significantly decreased in CR-treated AD mice; at the genus level, Dubosiella (10.04%), Faecalibaculum (0.04%), and Coriobacteriaceae UCG-002 (0.01%) were significantly increased in CR-treated AD mice by comparing with AL diet.

CONCLUSIONS:

Our results demonstrate that the attenuation of AD following CR treatment in APP/PS1 mice may result from alterations in the gut microbiome. Thus, gut flora could be a new target for AD prevention and therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camundongos Transgênicos / Precursor de Proteína beta-Amiloide / Restrição Calórica / Doença de Alzheimer / Microbioma Gastrointestinal Limite: Animals Idioma: En Revista: CNS Neurosci Ther Assunto da revista: NEUROLOGIA / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Camundongos Transgênicos / Precursor de Proteína beta-Amiloide / Restrição Calórica / Doença de Alzheimer / Microbioma Gastrointestinal Limite: Animals Idioma: En Revista: CNS Neurosci Ther Assunto da revista: NEUROLOGIA / TERAPEUTICA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
...